Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitis

BACKGROUND: Atypical antipsychotic agents (AAP) alleviate the symptoms of severe mental health disorders, such as schizophrenia, by antagonizing dopamine and serotonin receptors. Recently, AAP have also been shown to exhibit immunomodulatory properties in the central nervous system (CNS). OBJECTIVE:...

Full description

Saved in:
Bibliographic Details
Published in:Mult Scler J Exp Transl Clin
Main Authors: Green, Laura K, Zareie, Pirooz, Templeton, Nikki, Keyzers, Robert A, Connor, Bronwen, La Flamme, Anne Camille
Format: Artigo
Language:Inglês
Published: SAGE Publications 2017
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5453410/
https://ncbi.nlm.nih.gov/pubmed/28607752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217317698724
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items